Form 4 for ATYR aTYR PHARMA INC
Accepted 2026-05-28 16:12:51 ET · period of report 2026-05-27 · accession 0001236447-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-28 16:12 | 2026-05-27 | ATYR | SCHIMMEL PAUL | Dir | P - Purchase | $0.4963 | +100.0K | 779.1K | +15% | +$49.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-27 | P | A | 100,000 | $0.4963 | 779,143 | I See Footnote | — | — | (F1) Represents weighted average price for the shares. The shares were purchased at prices ranging from $0.4907 to $0.50 per share. The Reporting Person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. (F2) These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000. |